Virax Biolabs Group Limited Ordinary Shares

VRAX XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.6M

Short interest (May 15)

5.3%

Net Short (Jun 03 ): 6.2%

Borrow Fee

122.31%

↑ 95.2%

Available Shares

↓ 7.8%

Price Chart

Company Overview

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Company Info

Exchange: NASDAQ

CIK: 0001885827

Asset Type: CS

Market Data

Market Cap: $1,605,688

Employees: 19

Status: Active

Short Interest

Current Borrow Fee 122.31%

Range: 122.31% - 122.31%

Available Shares 0

Range: 0 - 50K

Recent Changes

Fee Change: ↑ 19.4%

Available Change: ↓ 88.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime